Skip to main content
Premium Trial:

Request an Annual Quote

Sanger Institute Purchases PacBio RS Single-Molecule Sequencer

Premium

The Wellcome Trust Sanger Institute has purchased a PacBio RS single-molecule sequencer as part of an expansion of Pacific Biosciences’ early-access program, the company said this week.

Earlier this year, PacBio named its first 10 early-access customers (IS 2/23/2010), all located in North America, several of who have received their instruments.

The Sanger Institute, which is expected to obtain its instrument before the end of the year, is the first European customer that PacBio has disclosed in the expansion of its early-access program beyond North America.

The company plans to ship instruments to a “limited number” of early-access sites outside of North America and previously said it is interested in having testing sites in Europe and Asia.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.